HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Henney confirmation hearing

This article was originally published in The Rose Sheet

Executive Summary

FDA commissioner-nominee Jane Henney, MD, tentatively scheduled to testify before the Senate Labor & Human Resources Committee Sept. 2. Committee Chairman James Jeffords (R-Vt.) had announced plans to hold the hearing Sept. 1 pending Henney's response to 140 questions posed to the candidate ("The Rose Sheet" Aug. 10, p. 1). In her Aug. 24 response, Henney discussed priorities for modernization of scientific standards, including color additives. Henney stated preference must be assigned to those standards "most likely to improve final regulatory decisions while maintaining public confidence." Henney also said she would protect FDA's existing programs from being cut to funds new initiatives, such as foods and tobacco...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005747

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel